Global longitudinal strain predicts survival and response in patients with systemic AL amyloidosis. analysis of 915 patients from the ALchemy prospective trial
31 August 2020 (08:30 - 08:40)
Organised by:
About the speaker

National Amyloidosis Centre, Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)
2 More presentations in this session
Access the full session
The Event
ESC Congress 2020
31 August 2020
08:30 CET




